SCHEMBL23309681

SCHEMBL23309681

CC(C)Oc1cccc(NC(=S)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 2/20 0.45
▸ PLAU P00749 2/20 0.43
▸ F2 P00734 1/20 0.43
▸ PLG P00747 1/20 0.43
▸ PLAT P00750 1/20 0.43
▸ KLKB1 P03952 1/20 0.43
▸ PRSS1 P07477 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ ALOX12 P18054 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ MAPT P10636 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ CCR6 P51684 1/20 0.41
▸ SYK P43405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309593 0.88 GRM4 (0.52) GRM4PLAUF2PLGPLAT
SCHEMBL23309513 0.77 RAB9A (0.63) GRM4ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL23309645 0.76 ALDH1A1 (0.51) ALDH1A1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL23309627 0.75 PLAU (0.60) GRM4PLAUF2PLGPLAT
SCHEMBL23309511 0.74 KMT2A (0.52) PLAUKLKB1RAB9ASMN1; SMN2NPC1
SCHEMBL23309612 0.74 GRM4 (0.47) GRM4ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL23309585 0.74 KDM4E (0.52) GRM4PLAUALDH1A1RAB9ASMN1; SMN2
SCHEMBL23309615 0.73 P2RX1 (0.58) GRM4ALDH1A1RAB9ANPC1MAPT
SCHEMBL23309501 0.72 FADS1 (0.56) SMN1; SMN2CA2MEN1KMT2AKCNK3
SCHEMBL23309536 0.70 MEN1 (0.55) ALDH1A1RAB9ASMN1; SMN2NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL GRM4 2885/4885PLAU 4582/4885F2 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback